Glass Lewis backs Aptose's plan for Hanmi acquisition; vote deadline March 27

Aptose Biosciences Inc.

Glass Lewis recommends shareholders vote FOR the arrangement with Hanmi and the continuance to ABCA.
Proxy voting deadline is 11:00 a.m. EST on Friday, March 27, 2026.
Special meeting reconvened for March 31, 2026, after SEC comments on the transaction statement.
Board and Special Transaction Committee unanimously recommend voting FOR the arrangement.
Deal is subject to court approval and TSX approval; Sodali & Co assisting with proxy solicitation.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.